Covered recipient · General Payments record
DALE E SOLOMON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,219.42
- Reported across 77 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.90 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $50.00 | 3 |
| PFIZER INC. | $37.23 | 2 |
| INOGEN, INC. | $33.33 | 2 |
| EISAI INC. | $24.06 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.37 | 1 |
| Lilly USA, LLC | $18.38 | 1 |
| Novo Nordisk AS | $14.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Eisai Inc. | $24.06 | 02/22/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1110738103 | CMS |
| GlaxoSmithKline, LLC. | $16.25 | 02/16/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116436905 | CMS |
| GlaxoSmithKline, LLC. | $17.92 | 02/23/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116622123 | CMS |
| GlaxoSmithKline, LLC. | $15.83 | 04/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116440265 | CMS |
| INOGEN, INC. | $18.55 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1144989467 | CMS |
| INOGEN, INC. | $14.78 | 07/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1144989469 | CMS |
| Lilly USA, LLC | $18.38 | 02/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1136123294 | CMS |
| Novo Nordisk Inc | $14.53 | 02/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1097682343 | CMS |
| PFIZER INC. | $21.59 | 05/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131435381 | CMS |
| PFIZER INC. | $15.64 | 07/31/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1132015599 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.37 | 06/18/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1153495840 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.